Carlton South Vic 3053, Australia
Go to Investors Hub
info@radiopharmtheranostics.com
Announcements

Radiopharm Theranostics
ASX Announcements

Stay fully informed with all investment-related announcements from Radiopharm Theranostics lodged with the ASX, including financial results, clinical trial updates, and corporate governance.

Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs
Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)
Dr. Oliver Sartor Appointed to Radiopharm Scientific Advisory Board
Radiopharm Receives $4.5M R&D Tax Incentive
Quarterly Activities & Cash Report
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for 161Tb-KLK3-mAb Phase I Clinical Trial in Australia
Notice Under Section 708A
Application for quotation of securities – RAD
RAD Granted US FDA Fast Track for RAD101 Metastases Imaging
Proposed issue of securities – RAD
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
RAD Reports Positive Preclinical Lu177-B7H3-mAb Data
Recent News
Categories
Analyst ReportsAnnouncementsAnnual ReportsInvestor PresentationsRAD ArticlesUpdates
Tags
Tags
Appendix 2A (1) Appendix 3B (1) Change of Director's Interest Notice (1) Cleansing Notice (1) PDF (22) Periodic Reports (24) Price Sensitive (84) Progress Report (2) Video (2) With Summary (2) With Video (4)
Archives
Archives
RSS RSS

Analyst Reports

Analyst Coverage

AnalystFirm
John HesterBell Porter (Australia)
Yuan Zhi, PhDB. Riley Securities
Kemp Dolliver, CFABrookline Capital Markets
Justin Walsh, PhDJones Trading
Jason McCarthy, PhDMaxim Group
Ashok Kumar, PhD, CFAThink Equity
John D. VandemostenZacks Small Cap Research
Zacks Small-Cap Research
Zachs Small-Cap Research RAD Initiating Coverage – Adding a Radio- isotope to Precision Oncology

Annual Reports

Annual Report
Annual Report to shareholders

Investor Presentations

RAD Presentation December 2025
CLINICAL UPDATE AND CAPITAL RAISING OCTOBER 20th, 2025
Presentation to Annual General Meeting
Presentation to Annual General Meeting
Close
Search

Hit enter to search or ESC to close

cookie By using this website, you agree to our cookie policy. Close